Page last updated: 2024-10-27

fenoldopam and Neoplasms

fenoldopam has been researched along with Neoplasms in 1 studies

Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
"D."1.33Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent. ( Finkel, K; Gubert, M; Johnson, T; Samuels, J; Shaw, A, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Samuels, J1
Finkel, K1
Gubert, M1
Johnson, T1
Shaw, A1

Other Studies

1 other study available for fenoldopam and Neoplasms

ArticleYear
Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent.
    Renal failure, 2005, Volume: 27, Issue:1

    Topics: Acute Kidney Injury; Adult; Aged; Critical Illness; Dopamine Agonists; Dose-Response Relationship, D

2005